
|Articles|December 10, 2021
Daily Medication Pearl: Glipizide (Glucotrol)
Author(s)Saro Arakelians, PharmD
Glipizide stimulates beta cells to produce more insulin in the body.
Advertisement
Medication Pearl of the Day: Glipizide (Glucotrol)
Indication: Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class.
Insight:
- Dosing: The recommended starting dose is 5 mg, given before breakfast. Geriatric patients or those with liver disease may be started on 2.5 mg.
- Dosage forms: 5 mg and 10 mg
- Adverse events: Includes gastrointestinal disturbances, erythema, low blood sugars, leukopenia, hyponatremia, dizziness, and drowsiness.
- Mechanism of action: Glipizide stimulates the beta cells of the pancreas to produce more insulin in the body.
- Manufacturer: Pfizer
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
3
Pharmacist Outreach Doubles SGLT2 Inhibitor Uptake in CKD
4
Could VER-01 Redefine the Role of Cannabis in Chronic Pain Care?
5





































































































